Xu Cao

1.2k total citations
64 papers, 780 citations indexed

About

Xu Cao is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Xu Cao has authored 64 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Epidemiology and 14 papers in Cancer Research. Recurrent topics in Xu Cao's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Xu Cao is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Xu Cao collaborates with scholars based in China, United Kingdom and United States. Xu Cao's co-authors include Xiaoke Li, Yongan Ye, Jiaxin Zhang, Hongbo Du, Guang Chen, Jiaying Zhang, Mei Han, Danan Gan, Peng Zhang and Qiuling Fan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Xu Cao

61 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Cao China 17 381 197 163 161 100 64 780
Hong Zhu China 19 450 1.2× 299 1.5× 165 1.0× 136 0.8× 131 1.3× 54 803
Liping Meng China 19 560 1.5× 151 0.8× 131 0.8× 149 0.9× 51 0.5× 51 1.1k
Yunjin Zang China 18 405 1.1× 298 1.5× 123 0.8× 147 0.9× 83 0.8× 50 760
Zhao Tang China 14 269 0.7× 155 0.8× 83 0.5× 122 0.8× 84 0.8× 37 626
Steffen Frese Switzerland 17 544 1.4× 108 0.5× 116 0.7× 151 0.9× 91 0.9× 26 979
Dong Wu China 16 353 0.9× 167 0.8× 159 1.0× 367 2.3× 61 0.6× 36 924
Ming Su China 15 381 1.0× 194 1.0× 320 2.0× 76 0.5× 150 1.5× 54 912
Zhenzhen Yao China 10 378 1.0× 145 0.7× 141 0.9× 150 0.9× 108 1.1× 17 802
Jinlin Yang China 16 594 1.6× 251 1.3× 195 1.2× 243 1.5× 129 1.3× 95 1.4k
Cuiling Qi China 19 545 1.4× 296 1.5× 87 0.5× 346 2.1× 39 0.4× 44 1.1k

Countries citing papers authored by Xu Cao

Since Specialization
Citations

This map shows the geographic impact of Xu Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Cao more than expected).

Fields of papers citing papers by Xu Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Cao. The network helps show where Xu Cao may publish in the future.

Co-authorship network of co-authors of Xu Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Cao. A scholar is included among the top collaborators of Xu Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Cao. Xu Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Ruosi, Yaxin Zhang, Xu Cao, et al.. (2025). Identification of a new micropeptide altKLF4 derived from KLF4 that influences myeloma chemotherapeutic sensitivity. Cellular Signalling. 131. 111767–111767. 1 indexed citations
2.
Cao, Xu, et al.. (2025). Multilayered insights into the full spectrum of diffuse gliomas: a novel prognostic evaluation model. Discover Oncology. 16(1). 1744–1744. 1 indexed citations
3.
Li, Xiaoke, et al.. (2025). Regulatory mechanisms of signaling pathways in liver cancer treatment with traditional Chinese medicine. Journal of Ethnopharmacology. 342. 119386–119386. 6 indexed citations
4.
Xue, Chengyuan, Xiaoke Li, Qiyao Liu, et al.. (2024). Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine. Frontiers in Pharmacology. 15. 1381476–1381476. 2 indexed citations
5.
Liu, Ruijia, et al.. (2024). Downregulation of ST6GAL2 Correlates to Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma. Journal of Inflammation Research. Volume 17. 565–580. 1 indexed citations
6.
Liang, Yijun, Wei Wang, Peng Zhang, et al.. (2024). Application of network pharmacology in traditional Chinese medicine for the treatment of digestive system diseases. Frontiers in Pharmacology. 15. 1412997–1412997. 6 indexed citations
7.
Qi, Wenying, et al.. (2024). Research Progress of Chinese Medicine in the Regulation of Liver Fibrosis-Related Signaling Pathways. The American Journal of Chinese Medicine. 52(6). 1693–1728. 1 indexed citations
8.
Guo, Ziwei, Tingyu Zhang, Jin Qian, et al.. (2023). Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study. Frontiers in Genetics. 14. 1108086–1108086. 16 indexed citations
9.
Cao, Xu, Yijun Liang, Ruijia Liu, et al.. (2022). Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy. Frontiers in Pharmacology. 13. 793888–793888. 12 indexed citations
10.
Wang, Xinxing, Song Wu, Lina Zhang, et al.. (2022). A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma. Frontiers in Oncology. 12. 1024915–1024915. 10 indexed citations
11.
Cao, Xu, Zhiguo Li, Xiaoke Li, et al.. (2022). Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma. Frontiers in Pharmacology. 13. 985084–985084. 5 indexed citations
12.
Zhang, Lína, et al.. (2022). A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma. Frontiers in Oncology. 12. 1085065–1085065. 7 indexed citations
13.
14.
Cao, Xu & Qiuling Fan. (2020). <p>LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 4507–4517. 21 indexed citations
15.
16.
Zhao, Hong, Bin Zhang, Yue Li, et al.. (2012). [Effect of gefitinib on the migration of triple-negative breast cancer cell line MDA-MB-231 cells].. PubMed. 34(2). 84–8. 1 indexed citations
17.
Zhang, Jiao, et al.. (2012). [Mammographic and pathological features of triple-negative breast cancer].. PubMed. 34(4). 291–5. 4 indexed citations
18.
Zhao, Hong, Bin Zhang, Hui Yao, et al.. (2010). Correlations between FGFR2 gene polymorphism and susceptibility of breast cancer. Clinical Oncology and Cancer Research. 37(11). 626–629. 2 indexed citations
19.
Zhang, Bin, et al.. (2008). [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].. PubMed. 37(7). 471–6. 4 indexed citations
20.
Cao, Xu, et al.. (2006). [Expression and clinical significance of KNSL4 in breast cancer].. PubMed. 25(6). 744–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Zhu Breakdown of academic impact, for papers by Liping Meng Breakdown of academic impact, for papers by Yunjin Zang Breakdown of academic impact, for papers by Zhao Tang Breakdown of academic impact, for papers by Steffen Frese Breakdown of academic impact, for papers by Dong Wu Breakdown of academic impact, for papers by Ming Su Breakdown of academic impact, for papers by Zhenzhen Yao Breakdown of academic impact, for papers by Jinlin Yang Breakdown of academic impact, for papers by Cuiling Qi
Rankless by CCL
2026